Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Warm Autoimmune Hemolytic Anemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05922839
What this trial is testing

Zanubrutinib in the Treatment of Relapsed/Refractory wAIHA

Who this might be right for
Warm Autoimmune Hemolytic Anemia
Chen Miao 22
Large-scale testing (Phase 3)Study completedNCT01134432
What this trial is testing

Prednisolone +/- Addition of Anti-CD20 Antibody, Rituximab, in Patients With Immune Hemolytic Anemia

Who this might be right for
Anemia, Hemolytic, Autoimmune
Copenhagen University Hospital at Herlev 65
Large-scale testing (Phase 3)Active Not RecruitingNCT05648968
What this trial is testing

Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic Anemia

Who this might be right for
Warm Autoimmune Hemolytic Anemia (wAIHA)
Novartis Pharmaceuticals 90
Testing effectiveness (Phase 2)UnknownNCT03827603
What this trial is testing

Ibrutinib in Steroid Refractory Autoimmune Hemolytic Anemia

Who this might be right for
AIHA - Warm Autoimmune Hemolytic Anemia
Eugene Nikitin 50
Large-scale testing (Phase 3)Study completedNCT01181154
What this trial is testing

Rituximab in Auto-Immune Hemolytic Anemia

Who this might be right for
Warm Autoimmune Hemolytic Anemia
Assistance Publique - Hôpitaux de Paris 32
Testing effectiveness (Phase 2)Study completedNCT04691570
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ANX005 in Participants With Warm Autoimmune Hemolytic Anemia (wAIHA)

Who this might be right for
Warm Autoimmune Hemolytic Anemia (wAIHA)
Annexon, Inc. 7
Large-scale testing (Phase 3)Looking for participantsNCT07086976
What this trial is testing

Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic Anemia

Who this might be right for
Autoimmune Haemolytic Anaemia
Sanofi 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT05002777
What this trial is testing

Efficacy, Safety and Pharmacokinetics of Rilzabrutinib in Patients With Warm Autoimmune Hemolytic Anemia (wAIHA)

Who this might be right for
Warm Autoimmune Hemolytic Anemia (wAIHA)
Sanofi 22
Testing effectiveness (Phase 2)Ended earlyNCT02389231
What this trial is testing

Evaluating the Interest of Interleukine-2 for Patients With Active Warm Hemolytic Anemia Resistant to Conventional Treatment

Who this might be right for
Autoimmune Hemolytic Anemia
University Hospital, Bordeaux 2
Large-scale testing (Phase 3)Active Not RecruitingNCT05535933
What this trial is testing

HMPL-523 (Sovleplenib) in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia

Who this might be right for
Warm Antibody Autoimmune Hemolytic Anemia
Hutchmed 111
Testing effectiveness (Phase 2)Ended earlyNCT04661033
What this trial is testing

Safety, Pharmacokinetics, and Efficacy of Subcutaneous Isatuximab in Adults With Warm Autoimmune Hemolytic Anemia (wAIHA)

Who this might be right for
Warm Autoimmune Hemolytic Anemia (wAIHA)
Sanofi 8
Testing effectiveness (Phase 2)Study completedNCT03226678
What this trial is testing

Study to Assess the Safety, Tolerability, Efficacy and PK of APL-2 in Patients With Warm Type Autoimmune Hemolytic Anemia (wAIHA) or Cold Agglutinin Disease (CAD)

Who this might be right for
Warm Autoimmune Hemolytic AnemiaCold Agglutinin Disease
Apellis Pharmaceuticals, Inc. 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07324889
What this trial is testing

An Open-label, Single-arm, Prospective, Multicenter, Phase I/II Clinical Study on the Safety and Efficacy of CD19/BCMA CAR-T Cell Therapy for Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia

Who this might be right for
Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia
Yihao Wang 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT04657094
What this trial is testing

Acalabrutinib for the Treatment of Relapsed or Refractory Autoimmune Hemolytic Anemia in Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Autoimmune Hemolytic AnemiaChronic Lymphocytic LeukemiaChronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma+1 more
City of Hope Medical Center 4
Testing effectiveness (Phase 2)Looking for participantsNCT07039422
What this trial is testing

Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From Ianalumab

Who this might be right for
Primary Immune ThrombocytopeniaWarm Autoimmune Hemolytic Anemia
Novartis Pharmaceuticals 60
Large-scale testing (Phase 3)Enrolling By InvitationNCT04138927
What this trial is testing

Open Label Extension Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia

Who this might be right for
Warm Antibody Autoimmune Hemolytic Anemia
Rigel Pharmaceuticals 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07190261
What this trial is testing

A Single-arm Phase 2 Prospective Clinical Study of Enatumab in the Treatment of Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia

Who this might be right for
Autoimmune Hemolytic Anemia
Bing Han 3
Testing effectiveness (Phase 2)UnknownNCT01579110
What this trial is testing

Efficacy and Safety of Levamisole Combined With Standard Prednisolone in Warm Antibody Autoimmune Hemolytic Anemia.

Who this might be right for
AnemiaAnemia, HemolyticAnemia, Hemolytic, Autoimmune+5 more
Institute of Hematology & Blood Diseases Hospital, China 100
Early research (Phase 1)Study completedNCT02502903
What this trial is testing

Safety, Tolerability and Activity of BIVV009 in Healthy Volunteers and Patients With Complement Mediated Disorders

Who this might be right for
Bullous Pemphigoid (BP)Cold Agglutinin Disease (CAD)Warm Autoimmune Hemolytic Anemia (WAIHA)+1 more
Bioverativ, a Sanofi company 122
Not applicableLooking for participantsNCT05925023
What this trial is testing

Sirolimus in the Treatment of Refractory/Relapsed wAIHA

Who this might be right for
Warm Autoimmune Hemolytic Anemia
Peking Union Medical College Hospital 22
Next Page